Copyright
©The Author(s) 2003.
World J Gastroenterol. Jun 15, 2003; 9(6): 1374-1376
Published online Jun 15, 2003. doi: 10.3748/wjg.v9.i6.1374
Published online Jun 15, 2003. doi: 10.3748/wjg.v9.i6.1374
Table 1 Pretreatment characteristics
| Characteristic | n | % |
| Age(years) | ||
| < 65 | 30 | 53.6 |
| ≥ 65 | 26 | 46.4 |
| Median | 59.5 | |
| Range | 40-74 | |
| Gender | ||
| Male | 41 | 73.2 |
| Female | 15 | 26.8 |
| T stage | ||
| T1 | 2 | 3.7 |
| T2 | 54 | 96.3 |
| Site | ||
| Cervical | 2 | 3.6 |
| Upper-thoracic | 19 | 33.9 |
| Middle-thoracic | 34 | 60.7 |
| Lower-thoracic | 1 | 1.8 |
| Length (cm) | ||
| ≤ 5 | 25 | 44.6 |
| > 5 | 31 | 55.4 |
| Median | 5.8 | |
| Range | 2.0-9.0 | |
| Thickness of wall (cm) | ||
| ≤ 1.5 | 42 | 75.0 |
| > 1.5 | 14 | 25 |
| Median | 1.2 | |
| Range | 0.5-2.7 | |
- Citation: Zhao KL, Wang Y, Shi XH. Late course accelerated hyperfractionated radiotherapy for clinical T1-2 esophageal carcinoma. World J Gastroenterol 2003; 9(6): 1374-1376
- URL: https://www.wjgnet.com/1007-9327/full/v9/i6/1374.htm
- DOI: https://dx.doi.org/10.3748/wjg.v9.i6.1374